Scarica l'app Stockscreener
1.39
0.00%
0.00
Precedente Chiudi:
$1.39
Aprire:
$1.39
Volume 24 ore:
175.27K
Relative Volume:
0.29
Capitalizzazione di mercato:
$74.13M
Reddito:
-
Utile/perdita netta:
$-77.74M
Rapporto P/E:
-0.9396
EPS:
-1.4793
Flusso di cassa netto:
$-73.61M
1 W Prestazione:
-3.47%
1M Prestazione:
+4.51%
6M Prestazione:
-1.42%
1 anno Prestazione:
+39.00%
Intervallo 1D:
$1.36
$1.39
Intervallo di 1 settimana:
$1.36
$1.488
Portata 52W:
$0.81
$1.88
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
Nome
Pmv Pharmaceuticals Inc
Settore
Industria
Telefono
(609) 642-6670
Indirizzo
400 ALEXANDER PARK DRIVE, PRINCETON
Compare PMVP vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.39 | 74.13M | 0 | -77.74M | -73.61M | -1.4793 |
VRTX
Vertex Pharmaceuticals Inc
|
423.92 | 107.83B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
701.42 | 73.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
783.50 | 48.72B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
296.11 | 39.51B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
293.86 | 32.66B | 5.36B | 287.73M | 924.18M | 2.5229 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-05-13 | Iniziato | Craig Hallum | Buy |
| 2024-04-12 | Iniziato | Jefferies | Buy |
| 2023-12-27 | Iniziato | Ladenburg Thalmann | Buy |
| 2022-03-02 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-09-22 | Aggiornamento | Goldman | Neutral → Buy |
| 2021-08-19 | Iniziato | Oppenheimer | Perform |
| 2021-08-02 | Iniziato | Guggenheim | Buy |
| 2021-07-29 | Iniziato | H.C. Wainwright | Buy |
| 2020-10-20 | Iniziato | BofA Securities | Buy |
| 2020-10-20 | Iniziato | Cowen | Outperform |
| 2020-10-20 | Iniziato | Evercore ISI | Outperform |
| 2020-10-20 | Iniziato | Goldman | Neutral |
Mostra tutto
Pmv Pharmaceuticals Inc Borsa (PMVP) Ultime notizie
PMV Pharmaceuticals (PMVP) to Release Earnings on Friday - MarketBeat
PMV Pharmaceuticals (PMVP) price target decreased by 37.50% to 4.84 - MSN
Short Interest in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Increases By 48.3% - MarketBeat
PMV Pharmaceuticals (PMVP) posts narrower than expected Q4 2025 loss, shares rise 1.37 percent in today's trading.Deceleration Risk - Newser
Is PMV Pharmaceuticals (PMVP) stock priced below intrinsic value (Institutional Demand) 2026-04-22Social Buy Zones - Cổng thông tin điện tử tỉnh Lào Cai
PMV Pharmaceuticals names Laurie Stelzer as board chair - Investing.com
PMV Pharmaceuticals chair Rich Heyman to depart, Laurie Stelzer to succeed - TipRanks
PMV Pharmaceuticals names Laurie Stelzer as board chair By Investing.com - Investing.com Canada
[ARS] PMV Pharmaceuticals, Inc. SEC Filing - Stock Titan
PMV Pharmaceuticals Announces Board Chair Transition - Weekly Voice
The Beauty Health Company Announces Corporate Rebrand to SkinHealth Systems, Reflecting Evolution into a Clinically Driven, Science-Backed Medical Aesthetics Platform - Weekly Voice
As PMV nears a 2027 drug filing, its board chair changes hands - Stock Titan
Board shifts and pay vote in PMV Pharmaceuticals (NASDAQ: PMVP) 2026 proxy - Stock Titan
Is PMV Pharmaceuticals (NASDAQ:PMVP) In A Good Position To Invest In Growth? - Yahoo Finance
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
PMV Pharmaceuticals (NASDAQ:PMVP) Stock Rating Upgraded by Evercore - MarketBeat
PMV Pharmaceuticals price target lowered to $4 from $16 at Evercore ISI - TipRanks
Stock List: Research Stocks from Around the World - GuruFocus
GUTS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Is PMV Pharmaceuticals (PMVP) Stock Breaking Resistance | Price at $1.29, Down 0.77%Social Trading - Newser
Energy Moves: Will PMV Pharmaceuticals Inc outperform its industry peers2026 Momentum & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Dividend Watch: Is PMV Pharmaceuticals Inc exposed to currency risksQuarterly Earnings Report & Daily Growth Stock Investment Tips - baoquankhu1.vn
Quarterly Recap: Is Edgewell Personal Care Company forming bullish engulfing patternsIPO Watch & Growth Focused Entry Reports - baoquankhu1.vn
PLRX PE Ratio & Valuation, Is PLRX Overvalued - Intellectia AI
PMVP Stock Analysis: PMV Pharmaceuticals Inc Biotech Performance At 1.34 Price - Cổng thông tin điện tử tỉnh Lào Cai
Cantargia AB (7V3.DU) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
PMVP SEC FilingsPmv Pharmaceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Sees Large Growth in Short Interest - MarketBeat
Aug Closing: Is PMV Pharmaceuticals Inc exposed to currency risks2026 Market Sentiment & Target Return Focused Stock Picks - baoquankhu1.vn
ICCC PE Ratio & Valuation, Is ICCC Overvalued - Intellectia AI
Why EXEL stock attracts strong analyst attention - baoquankhu1.vn
Analyst Upgrade: Is PMV Pharmaceuticals Inc benefiting from interest rate changesInflation Watch & Verified Swing Trading Watchlists - baoquankhu1.vn
Complete List of HealthcareBiotechnologyBiotechnology Stocks - GuruFocus
PMV Pharmaceuticals Insider Sellers Vindicated After 11% Drop - simplywall.st
Aug Swings: Is PMV Pharmaceuticals Inc exposed to currency risksDip Buying & Low Volatility Stock Recommendations - baoquankhu1.vn
US Market Wrap: Is PMV Pharmaceuticals Inc a potential multi bagger2026 Volatility Report & Growth Focused Stock Reports - baoquankhu1.vn
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Short Interest Update - MarketBeat
PMV Pharmaceuticals Advances Rezatapopt Interaction Study, Signaling Steady Progress in TP53-Driven Oncology - TipRanks
PMV Pharmaceuticals (PMVP) CFO receives 240,000-share stock option grant - Stock Titan
COO at PMV Pharmaceuticals (NASDAQ: PMVP) awarded 319,270 options - Stock Titan
PMV Pharmaceuticals (PMVP) awards 303,310 stock options to Chief Development Officer - Stock Titan
PMV Pharmaceuticals (PMVP) awards CEO 744,960 employee stock options - Stock Titan
PMV Pharmaceuticals (NASDAQ:PMVP) Issues Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat
Trend Recap: Does TriNet Group Inc have pricing powerEarnings Overview Summary & Safe Capital Growth Stock Tips - baoquankhu1.vn
PMV Pharmaceuticals, Inc.Common Stock (NQ: PMVP - The Chronicle-Journal
Risk On: Whats the outlook for PMV Pharmaceuticals Incs sectorWeekly Trend Report & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
PMV Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
PMVP Reports Positive Phase 2 Results, Eyes 2027 NDA Submission - GuruFocus
PMV Pharma (PMVP) Reports Decline in Cash Reserves by Year-End 2 - GuruFocus
PMV Pharmaceuticals Reports Progress in PYNNACLE Trial of Rezatapopt for Ovarian Cancer and Announces Orphan Drug Designation from FDA - Quiver Quantitative
PMV Pharmaceuticals 10-K: Revenue $0, EPS $(1.48) — FY2025 results - TradingView
Pmv Pharmaceuticals Inc Azioni (PMVP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Pmv Pharmaceuticals Inc Azioni (PMVP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% Owner |
Oct 23 '25 |
Sale |
1.52 |
1,000,000 |
1,520,000 |
4,975,291 |
2.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):